Ischemic damage increases nitric oxide production via inducible nitric oxide synthase in the cochlea

  • Isao Morizane
  • , Nobuhiro Hakuba
  • , Jun Hyodo
  • , Yoshitaka Shimizu
  • , Kensuke Fujita
  • , Tadashi Yoshida
  • , Kiyofumi Gyo

Research output: Contribution to journalArticlepeer-review

28 Scopus citations

Abstract

The present study was designed to elucidate the dynamic changes of nitric oxide (NO) production in the perilymph and to investigate the immunostaining for inducible nitric oxide synthase (iNOS) in the cochlea for 7 days after transient cochlear ischemia. Moreover, aminoguanidine, which is a selective iNOS inhibitor, was administrated immediately following ischemia and every 24 h thereafter for 7 days to investigate whether the production of NO is dependent on the iNOS pathway. Significant increases in the oxidative NO metabolites, nitrite (NO2-) and nitrate (NO3-), were measured on day 1 using an in vivo microdialysis and on-line high performance liquid chromatography (HPLC) system. The immunostaining for iNOS was strongly expressed on days 1 and 4 and returned to normal on day 7 after the ischemia. The administration of aminoguanidine reduced the oxidative NO metabolites on day 1 and suppressed the expression of iNOS. These findings suggest that transient ischemia causes a remarkable increase in NO production in the perilymph, which might be attributable to the iNOS pathway.

Original languageEnglish
Pages (from-to)62-67
Number of pages6
JournalNeuroscience Letters
Volume391
Issue number1-2
DOIs
StatePublished - 31 Dec 2005
Externally publishedYes

Keywords

  • Aminoguanidine
  • Inducible nitric oxide synthase (iNOS)
  • Nitric oxide (NO)
  • Transient cochlear ischemia

Fingerprint

Dive into the research topics of 'Ischemic damage increases nitric oxide production via inducible nitric oxide synthase in the cochlea'. Together they form a unique fingerprint.

Cite this